SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-131284
Filing Date
2021-10-28
Accepted
2021-10-28 21:04:36
Documents
2
Period of Report
2021-10-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2131250-11_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2131250-11_3seq1.xml 3 6157
2 EXHIBIT 24 tm2131250d11_ex24.htm EX-24 11062
  Complete submission text file 0001104659-21-131284.txt   19444
Mailing Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070
Business Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070 9732354295
ROCHE HOLDING LTD (Reporting) CIK: 0000889131 (see all company filings)

State of Incorp.: V8
Type: 3 | Act: 34 | File No.: 001-40969 | Film No.: 211360230
SIC: 8880 American Depositary Receipts

Mailing Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
Business Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
ROCHE FINANCE LTD (Reporting) CIK: 0001053942 (see all company filings)

State of Incorp.: V8
Type: 3 | Act: 34 | File No.: 001-40969 | Film No.: 211360229

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations